Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed Papers
Melanoma cell adhesion molecule identifies encephalitogenic T lymphocytes and promotes their recruitment to the central nervous system.
International consensus diagnostic criteria for neuromyelitis optica spectrum disorders.
Assessing the long-term clinical benefit of prolonged-release fampridine tablets in a real-world setting: a review of 67 cases.
Incidence of therapy-related acute leukaemia in mitoxantrone-treated multiple sclerosis patients in Germany.
Patients' experiences of adapting to multiple sclerosis: a qualitative study.
Simultaneous PML-IRIS after discontinuation of natalizumab in a patient with MS.
A pilot study of the immunological effects of high-dose vitamin D in healthy volunteers.
Substance Name: Riluzole
Structure and signalling in the IL-17 receptor family.
Brainstem PML lesion mimicking MS plaque in a natalizumab-treated MS patient.
Fingolimod (FTY720) therapy in Japanese patients with relapsing multiple sclerosis over 12 months: results of a phase 2 observational extension.
Geographical Variations in Sex Ratio Trends over Time in Multiple Sclerosis.
Multiple sclerosis: basic knowledge and new insights in perioperative management.
Monoclonal Antibodies in the Treatment of Neuroimmunological Diseases.
Licensing of myeloid cells promotes central nervous system autoimmunity and is controlled by peroxisome proliferator-activated receptor γ
First patient enrolled in third Phase III study of oral laquinimod for relapsing-remitting multiple sclerosis
Dynamics of saccade parameters in multiple sclerosis patients with fatigue.
Combined treatment with minocycline and prednisone attenuates experimental autoimmune encephalomyelitis in C57 BL/6 mice.
Long-term subcutaneous interferon beta-1a therapy in patients with relapsing-remitting MS.
Comparison of DNA-Hydrolyzing Antibodies from the Cerebrospinal Fluid and Serum of Patients with Multiple Sclerosis.
[Physical rehabilitation in multiple sclerosis: general principles and high-tech approaches].
Effect of open label pulse cyclophosphamide therapy on MRI measures of disease activity in five patients with refractory relapsing-remitting multiple sclerosis.
Symptoms, Prevalence and Impact of Multiple Sclerosis in Younger Patients: A Multinational Survey.
Sex as a determinant of relapse incidence and progressive course of multiple sclerosis.
Fatigue and Depression in Children With Demyelinating Disorders.
Pages
« first
‹ previous
…
165
166
167
168
169
170
171
172
173
…
next ›
last »